RxDoctor Payments Data

Mandy McAllister

Family · Hannibal, MONPI 1639522873

Payments from drug & device makers

$666in general payments, 2019–2025

Across 42 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$365
  • Madrigal Pharmaceuticals$78
  • Intercept Pharmaceuticals, Inc.$39
  • Phathom Pharmaceuticals, Inc.$29
  • Boston Scientific$29
  • Takeda Pharmaceuticals U.S.A., Inc.$26
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 60th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$22,476
Medicare patients
230
Services billed
333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OcalivaObeticholic Acid21$207,459
Entyvio PenVedolizumab22$135,075
RezdiffraResmetirom30$119,100
LinzessLinaclotide78$50,423
ViberziEluxadoline27$48,420
XifaxanRifaximin11$29,874
CreonLipase/Protease/Amylase11$18,800
TrulancePlecanatide21$15,351
Dexlansoprazole DrDexlansoprazole27$9,650
Ursodiol43$8,510
ErythromycinErythromycin Base17$7,157
MovantikNaloxegol Oxalate15$6,495
EliquisApixaban16$6,419
Mesalamine13$4,851
Sucralfate46$3,977

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Intercept Pharmaceuticals, Inc.Ocaliva$39$207,45921 claims
Madrigal PharmaceuticalsRezdiffra$78$119,10030 claims
AbbVieLinzess, Viberzi, Creon$365$117,644116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,812 family providers in Missouri.

Other family in Hannibal

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →